CORE C: ABSTRACT This ADRC has comprehensive and demanding translational research objectives, for which the Data Management and Statistics (DMS) core must be able to efficiently collect, validate, integrate, and derive meaning from a complex array of data. Key questions about diagnosis, clinical features, natural history, interactions between genotype and phenotype, clinico-pathological relationships, and connections between structural and functional brain changes and neurobehavioral disturbances can only be addressed with sophisticated and comprehensive data structures, and with the support of a cohesive team of expert statistical personnel. Thus, the DMS Core for this ADRC has a particular mandate to support and facilitate our researchers'ability to link the complex, multilevel data we collect, and to approach that data with the sophisticated and appropriate recommendations for research design and analytic methods. In the next phase of this ADRC, we will incorporate new innovations to the DMS that will enable our researchers to better identify and integrate multilevel data collected through the ADRC, while enabling us to link ADRC data with other resources at UCSF. Historically, the UCSF Memory and Aging Center (MAC) has shown national leadership in developing data management systems that integrate a wealth of information from a variety of sources in order to better understand the etiology and treatment of dementia syndromes and promote translational research. The core mandate of this DMS is to ensure that: (1) the measurement of behavioral, cognitive, neurological, imaging and genetic information is supported by scientifically sound techniques that result in a consistent classification of information (i.e., results are reliable and reproducible);(2) that the observed phenomena are accurately recorded and reflected in the database;(3) that the database is secure, preventing unauthorized changes;(4) that analytical data sets are easily accessible to collaborating investigators within and beyond the ADRC;and (5) that meaningful patterns in the data are identified using appropriate and efficient research design and statistical methods. We plan to augment these core functions by elaborating our representation of multiple levels of neurological information in order to improve our ability to model complex patterns and associations in our patients. We have also enhanced our plan for delivery of statistical consultation and have added biostatistical personnel. These improvements will build upon the solid foundation that we have established, and ensure that we will continue to provide the program structure required for the highest level of data collection, management, quality control, and timely NACC data submission.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG023501-11
Application #
8677145
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4 (J1))
Project Start
2014-04-01
Project End
2019-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
11
Fiscal Year
2014
Total Cost
$157,454
Indirect Cost
$57,455
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Mok, Sue-Ann; Condello, Carlo; Freilich, Rebecca et al. (2018) Mapping interactions with the chaperone network reveals factors that protect against tau aggregation. Nat Struct Mol Biol 25:384-393
Tan, Chin Hong; Fan, Chun Chieh; Mormino, Elizabeth C et al. (2018) Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol 135:85-93
Erkkinen, Michael G; Zúñiga, Raquel Gutiérrez; Pardo, Cristóbal Carnero et al. (2018) Artistic Renaissance in Frontotemporal Dementia. JAMA 319:1304-1306
Sturm, Virginia E; Brown, Jesse A; Hua, Alice Y et al. (2018) Network Architecture Underlying Basal Autonomic Outflow: Evidence from Frontotemporal Dementia. J Neurosci 38:8943-8955
Schneider, Raphael; McKeever, Paul; Kim, TaeHyung et al. (2018) Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study. J Neurol Neurosurg Psychiatry 89:851-858
Bonham, Luke W; Geier, Ethan G; Steele, Natasha Z R et al. (2018) Insulin-Like Growth Factor Binding Protein 2 Is Associated With Biomarkers of Alzheimer's Disease Pathology and Shows Differential Expression in Transgenic Mice. Front Neurosci 12:476
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Scheltens, Nienke M E; Tijms, Betty M; Heymans, Martijn W et al. (2018) Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression. J Alzheimers Dis 65:1029-1039
Karch, Celeste M; Wen, Natalie; Fan, Chun C et al. (2018) Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum. JAMA Neurol 75:860-875

Showing the most recent 10 out of 590 publications